Human Health Effects of Drinking Water Exposures to Per- and Polyfluoroalkyl Substances (PFAS) at Pease International Tradeport, Portsmouth, NH (The Pease Study)
ICR 201908-0923-001
OMB: 0923-0061
Federal Form Document
⚠️ Notice: This information collection may be outdated. More recent filings for OMB 0923-0061 can be found here:
Human Health Effects of
Drinking Water Exposures to Per- and Polyfluoroalkyl Substances
(PFAS) at Pease International Tradeport, Portsmouth, NH (The Pease
Study)
New
collection (Request for a new OMB Control Number)
Consistent with
the Supporting Statement, the statistical power and sampling frame
of this proof of concept study limits ATSDR’s ability to detect
moderate differences (between exposed and nonexposed individuals)
in many of health conditions queried in this collection. Approval
for the collection of information about conditions for which there
is not adequate statistical power is provided specifically for the
purposes of evaluating the study procedures, methods, and
hypotheses for a future multi-site study. Approval is provided
contingent upon a commitment to investigate other contributing
environmental factors when associations or trends are observed
between PFAS exposure and health conditions. Approval is also
provided contingent upon a commitment to work with the National
Center for Health Statistics on disclosure review procedures and
include a member of NCHS’s disclosure review board for NHANES on
the PEAS disclosure review board.
Inventory as of this Action
Requested
Previously Approved
08/31/2022
36 Months From Approved
5,852
0
0
1,454
0
0
42,227
0
0
The Pease Study will serve as a
proof-of-concept model for a multi-site study of PFAS health
effects. The existence of a large body of state and local
environmental monitoring and population blood testing data makes
the Pease community in Portsmouth, NH particularly suitable as
ATSDR’s initial PFAS research study site. The main goals of the
research study are to: 1) evaluate the study procedures and methods
to identify any changes to the design or protocol that need to be
made before embarking on a multi-site study; and 2) examine
associations between a limited number of health outcomes for which
statistical power is adequate and measured and historically
reconstructed serum levels of PFAS (e.g., lipids, renal function
and kidney disease, thyroid hormones and disease, liver function
and disease, glycemic parameters and diabetes, as well as immune
response and function in both children and adults).
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.